首页|MED25基因变异所致Basel-Vanagaite-Smirin-Yosef综合征临床表型及基因变异分析

MED25基因变异所致Basel-Vanagaite-Smirin-Yosef综合征临床表型及基因变异分析

扫码查看
目的 探讨Basel-Vanagaite-Smirin-Yosef综合征(BVSYS)的临床表型及基因变异情况,提高临床医生对该病的认识。方法 收集青岛大学附属青岛妇女儿童医院神经康复科2023年2月收住院的1例BVSYS患儿的临床资料,应用全基因组测序分析患儿的致病基因,使用Sanger测序验证其家系成员的可疑变异位点,进行临床表型及基因变异分析,并结合相关文献总结BVSYS的临床特点。结果 患儿女性,3岁1个月,主要表现为全面性发育迟缓、语言障碍、特殊面容、内斜视、癫痫、肌张力低下、房间隔缺损,头颅磁共振成像提示双侧脑室宽、双侧脑室体后旁异常信号、胼胝体细薄。全基因组测序发现患儿MED25基因存在纯合错义变异c。518(exon5)T>C(p。IIe173Thr),Sanger 测序结果提示其父母、哥哥均携带上述杂合变异,根据美国医学遗传学与基因组学学会指南评级为可能致病性变异。检索到英文文献6篇共报道22例患者,尚无中国病例报道。结论 BVSYS临床罕见。对于不明原因全面性发育迟缓/智力障碍合并颅面、神经、心脏和眼部异常的患者,进行针对性基因检测有助于明确诊断。
Clinical phenotype and gene variation analysis of MED25 gene mutation induced Basel-Vanagaite-Smirin-Yosef syndrome
Objective To investigate the clinical phenotype and genetic variation of Basel-Vanagaite-Smirin-Yosef syndrome(BVSYS),and to enhance clinicians'knowledge of the disease.Methods The clinical data of a child with BVSYS admitted to the Department of Neurological Rehabilitation,Qingdao Women and Children's Hospital Affiliated to Qingdao University in February 2023 were collected.Whole genome sequencing was used to analyze the pathogenic genes of the child,and Sanger sequencing was used to verify the suspected mutation sites of the family members.The clinical phenotype and genetic variation characteristics were analyzed,and the clinical characteristics of BVSYS were summarized in combination with relevant literature.Results The patient,a female aged 3 years and 1 month,presented with global developmental delay,speech disorder,distinctive facial features,esotropia,epilepsy,hypotonia and atrial septal defect.Brain magnetic resonance imaging revealed bilateral ventriculomegaly with abnormal signal intensity in the posterior bodies of both lateral ventricles and thinning of the corpus callosum.The whole genome sequencing revealed a homozygous missense mutation c.518(exon5)T>C(p.Ile173Thr)in the MED25 gene of the child,and Sanger sequencing confirmed that her parents and elder brother carried the aforementioned heterozygous mutation,which was classified as a likely pathogenic mutation according to the guidelines of the American College of Medical Genetics and Genomics.A total of 22 cases from 6 literature sources were retrieved,with no reported cases in China so far.Conclusions BVSYS is clinically rare.For patients presenting with unexplained global developmental delay or intellectual disability combined with craniofacial,neurological,cardiac,and eye abnormalities,targeted genetic testing can facilitate a definite diagnosis.

J Child development disordersIntelligenceEpilepsyMED25 geneBasel-Vanagaite-Smirin-Yosef syndrome

罗光金、张璇、陈潇、王丽华、赵静、丁晓、陈军、王利江、苑爱云、侯梅

展开 >

青岛大学附属青岛妇女儿童医院神经康复科,青岛 266034

青岛大学附属青岛妇女儿童医院儿内科,青岛 266034

青岛大学附属青岛妇女儿童医院脑电图室,青岛 266034

青岛大学附属青岛妇女儿童医院影像科,青岛 266034

展开 >

儿童发育障碍 智力 癫痫 MED25基因 Basel-Vanagaite-Smirin-Yosef综合征

山东省医药卫生科技发展计划项目

202206010061

2024

中华神经科杂志
中华医学会

中华神经科杂志

CSTPCD北大核心
影响因子:1.329
ISSN:1006-7876
年,卷(期):2024.57(1)
  • 13